Evidence map›Paper›PMID 38003019›Full record

ArticleGenes2023

C8ORF88: A Novel eIF4E-Binding Protein.

Lauren Pugsley, Sai Kiran Naineni, Mehdi Amiri, Akiko Yanagiya, Regina Cencic, Nahum Sonenberg, Jerry Pelletier

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lauren PugsleyDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.ORCID 0000-0002-2844-3335
Sai Kiran NaineniDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.
Mehdi AmiriDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.
Akiko YanagiyaArcalis, Inc., Kashiwa 277-0871, Japan.ORCID 0000-0002-5553-0311
Regina CencicDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.
Nahum SonenbergDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.ORCID 0000-0002-4707-8759
Jerry PelletierDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.
McGill University · CA

Funding

CIHR FDN-148366
6 · The paper itself

Abstract

Translation initiation in eukaryotes is regulated at several steps, one of which involves the availability of the cap binding protein to participate in cap-dependent protein synthesis. Binding of eIF4E to translational repressors (eIF4E-binding proteins [4E-BPs]) suppresses translation and is used by cells to link extra- and intracellular cues to protein synthetic rates. The best studied of these interactions involves repression of translation by 4E-BP1 upon inhibition of the PI3K/mTOR signaling pathway. Herein, we characterize a novel 4E-BP, C8ORF88, whose expression is predominantly restricted to early spermatids. C8ORF88:eIF4E interaction is dependent on the canonical eIF4E binding motif (4E-BM) present in other 4E-BPs. Whereas 4E-BP1:eIF4E interaction is dependent on the phosphorylation of 4E-BP1, these sites are not conserved in C8ORF88 indicating a different mode of regulation.

Indexed as

Carrier ProteinsEukaryotic Initiation Factor-4EPhosphoproteinsPhosphorylationProtein BindingCarrier ProteinsEukaryotic Initiation Factor-4EPhosphoproteinsC8ORF88cap-dependent translationeIF4Egene expressionmRNAprotein synthesistranslation initiation

Identifiers

PMID38003019
PMCPMC10670996
OpenAlexW4388660964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.